nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—ALOX5—Sulfasalazine—ankylosing spondylitis	0.626	0.645	CbGbCtD
Zileuton—PTGS1—Sulfasalazine—ankylosing spondylitis	0.141	0.145	CbGbCtD
Zileuton—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0435	0.0448	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0329	0.0339	CbGbCtD
Zileuton—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0283	0.0291	CbGbCtD
Zileuton—CYP3A4—Betamethasone—ankylosing spondylitis	0.0283	0.0291	CbGbCtD
Zileuton—CYP3A4—Prednisolone—ankylosing spondylitis	0.0279	0.0287	CbGbCtD
Zileuton—CYP3A4—Prednisone—ankylosing spondylitis	0.0263	0.0271	CbGbCtD
Zileuton—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0164	0.0169	CbGbCtD
Zileuton—Chronic liver disease—Methotrexate—ankylosing spondylitis	0.0051	0.174	CcSEcCtD
Zileuton—Liver disorder—Methotrexate—ankylosing spondylitis	0.000538	0.0184	CcSEcCtD
Zileuton—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000475	0.0162	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000404	0.0138	CcSEcCtD
Zileuton—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.000367	0.0125	CcSEcCtD
Zileuton—Vaginal infection—Methotrexate—ankylosing spondylitis	0.000347	0.0118	CcSEcCtD
Zileuton—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.000329	0.0112	CcSEcCtD
Zileuton—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.000324	0.0111	CcSEcCtD
Zileuton—Lymphadenopathy—Methotrexate—ankylosing spondylitis	0.000312	0.0107	CcSEcCtD
Zileuton—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.000302	0.0103	CcSEcCtD
Zileuton—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000274	0.00937	CcSEcCtD
Zileuton—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000274	0.00937	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000245	0.00838	CcSEcCtD
Zileuton—Malaise—Prednisolone—ankylosing spondylitis	0.000238	0.00814	CcSEcCtD
Zileuton—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000225	0.0077	CcSEcCtD
Zileuton—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000225	0.00769	CcSEcCtD
Zileuton—Discomfort—Prednisolone—ankylosing spondylitis	0.000222	0.0076	CcSEcCtD
Zileuton—Malaise—Triamcinolone—ankylosing spondylitis	0.000219	0.00749	CcSEcCtD
Zileuton—Malaise—Methylprednisolone—ankylosing spondylitis	0.000219	0.00747	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000214	0.00731	CcSEcCtD
Zileuton—Myalgia—Triamcinolone—ankylosing spondylitis	0.000207	0.00707	CcSEcCtD
Zileuton—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000206	0.00705	CcSEcCtD
Zileuton—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000206	0.00705	CcSEcCtD
Zileuton—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000205	0.00699	CcSEcCtD
Zileuton—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000205	0.00699	CcSEcCtD
Zileuton—Discomfort—Triamcinolone—ankylosing spondylitis	0.000204	0.00698	CcSEcCtD
Zileuton—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000204	0.00697	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.0002	0.00682	CcSEcCtD
Zileuton—Malaise—Dexamethasone—ankylosing spondylitis	0.000199	0.00679	CcSEcCtD
Zileuton—Malaise—Betamethasone—ankylosing spondylitis	0.000199	0.00679	CcSEcCtD
Zileuton—Insomnia—Prednisolone—ankylosing spondylitis	0.000195	0.00667	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—ankylosing spondylitis	0.000188	0.00641	CcSEcCtD
Zileuton—Myalgia—Betamethasone—ankylosing spondylitis	0.000188	0.00641	CcSEcCtD
Zileuton—Discomfort—Betamethasone—ankylosing spondylitis	0.000185	0.00634	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—ankylosing spondylitis	0.000185	0.00634	CcSEcCtD
Zileuton—Pain—Prednisolone—ankylosing spondylitis	0.000184	0.0063	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—ankylosing spondylitis	0.000184	0.0063	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000181	0.00617	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00018	0.00616	CcSEcCtD
Zileuton—Insomnia—Triamcinolone—ankylosing spondylitis	0.000179	0.00613	CcSEcCtD
Zileuton—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000179	0.00612	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000178	0.00609	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000178	0.00607	CcSEcCtD
Zileuton—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000175	0.00597	CcSEcCtD
Zileuton—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000174	0.00595	CcSEcCtD
Zileuton—Malaise—Prednisone—ankylosing spondylitis	0.000173	0.00592	CcSEcCtD
Zileuton—Urticaria—Prednisolone—ankylosing spondylitis	0.000171	0.00585	CcSEcCtD
Zileuton—Pain—Triamcinolone—ankylosing spondylitis	0.00017	0.0058	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000164	0.0056	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000164	0.0056	CcSEcCtD
Zileuton—Myalgia—Prednisone—ankylosing spondylitis	0.000163	0.00559	CcSEcCtD
Zileuton—Arthralgia—Prednisone—ankylosing spondylitis	0.000163	0.00559	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000163	0.00558	CcSEcCtD
Zileuton—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000163	0.00557	CcSEcCtD
Zileuton—Insomnia—Betamethasone—ankylosing spondylitis	0.000163	0.00556	CcSEcCtD
Zileuton—Insomnia—Dexamethasone—ankylosing spondylitis	0.000163	0.00556	CcSEcCtD
Zileuton—Discomfort—Prednisone—ankylosing spondylitis	0.000162	0.00552	CcSEcCtD
Zileuton—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000159	0.00543	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000158	0.00541	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000158	0.00541	CcSEcCtD
Zileuton—Urticaria—Triamcinolone—ankylosing spondylitis	0.000158	0.00538	CcSEcCtD
Zileuton—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000157	0.00537	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000157	0.00536	CcSEcCtD
Zileuton—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000155	0.00531	CcSEcCtD
Zileuton—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000155	0.00531	CcSEcCtD
Zileuton—Pain—Betamethasone—ankylosing spondylitis	0.000154	0.00526	CcSEcCtD
Zileuton—Pain—Dexamethasone—ankylosing spondylitis	0.000154	0.00526	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000149	0.00509	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000148	0.00507	CcSEcCtD
Zileuton—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000148	0.00507	CcSEcCtD
Zileuton—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000146	0.00499	CcSEcCtD
Zileuton—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000146	0.00498	CcSEcCtD
Zileuton—Malaise—Methotrexate—ankylosing spondylitis	0.000145	0.00495	CcSEcCtD
Zileuton—Urticaria—Dexamethasone—ankylosing spondylitis	0.000143	0.00489	CcSEcCtD
Zileuton—Urticaria—Betamethasone—ankylosing spondylitis	0.000143	0.00489	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000143	0.00488	CcSEcCtD
Zileuton—Dizziness—Prednisolone—ankylosing spondylitis	0.000143	0.00487	CcSEcCtD
Zileuton—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000142	0.00486	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000142	0.00486	CcSEcCtD
Zileuton—Insomnia—Prednisone—ankylosing spondylitis	0.000142	0.00484	CcSEcCtD
Zileuton—Pruritus—Triamcinolone—ankylosing spondylitis	0.00014	0.00479	CcSEcCtD
Zileuton—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00014	0.00478	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—ankylosing spondylitis	0.000138	0.00471	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—ankylosing spondylitis	0.000137	0.00467	CcSEcCtD
Zileuton—Chest pain—Methotrexate—ankylosing spondylitis	0.000137	0.00467	CcSEcCtD
Zileuton—Myalgia—Methotrexate—ankylosing spondylitis	0.000137	0.00467	CcSEcCtD
Zileuton—Rash—Prednisolone—ankylosing spondylitis	0.000136	0.00465	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—ankylosing spondylitis	0.000136	0.00464	CcSEcCtD
Zileuton—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000135	0.00463	CcSEcCtD
Zileuton—Headache—Prednisolone—ankylosing spondylitis	0.000135	0.00462	CcSEcCtD
Zileuton—Discomfort—Methotrexate—ankylosing spondylitis	0.000135	0.00461	CcSEcCtD
Zileuton—Constipation—Prednisone—ankylosing spondylitis	0.000134	0.00458	CcSEcCtD
Zileuton—Dizziness—Triamcinolone—ankylosing spondylitis	0.000131	0.00448	CcSEcCtD
Zileuton—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000131	0.00447	CcSEcCtD
Zileuton—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000129	0.00441	CcSEcCtD
Zileuton—Nausea—Prednisolone—ankylosing spondylitis	0.000128	0.00438	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—ankylosing spondylitis	0.000127	0.00435	CcSEcCtD
Zileuton—Pruritus—Betamethasone—ankylosing spondylitis	0.000127	0.00435	CcSEcCtD
Zileuton—Vomiting—Triamcinolone—ankylosing spondylitis	0.000126	0.00431	CcSEcCtD
Zileuton—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000126	0.0043	CcSEcCtD
Zileuton—Rash—Triamcinolone—ankylosing spondylitis	0.000125	0.00427	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000125	0.00427	CcSEcCtD
Zileuton—Rash—Methylprednisolone—ankylosing spondylitis	0.000125	0.00426	CcSEcCtD
Zileuton—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000125	0.00426	CcSEcCtD
Zileuton—Urticaria—Prednisone—ankylosing spondylitis	0.000124	0.00425	CcSEcCtD
Zileuton—Headache—Triamcinolone—ankylosing spondylitis	0.000124	0.00425	CcSEcCtD
Zileuton—Headache—Methylprednisolone—ankylosing spondylitis	0.000124	0.00424	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—ankylosing spondylitis	0.000124	0.00423	CcSEcCtD
Zileuton—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000123	0.00421	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000123	0.00421	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000119	0.00408	CcSEcCtD
Zileuton—Dizziness—Betamethasone—ankylosing spondylitis	0.000119	0.00407	CcSEcCtD
Zileuton—Dizziness—Dexamethasone—ankylosing spondylitis	0.000119	0.00407	CcSEcCtD
Zileuton—Insomnia—Methotrexate—ankylosing spondylitis	0.000118	0.00405	CcSEcCtD
Zileuton—Nausea—Triamcinolone—ankylosing spondylitis	0.000118	0.00403	CcSEcCtD
Zileuton—Nausea—Methylprednisolone—ankylosing spondylitis	0.000118	0.00402	CcSEcCtD
Zileuton—Somnolence—Methotrexate—ankylosing spondylitis	0.000116	0.00398	CcSEcCtD
Zileuton—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000115	0.00395	CcSEcCtD
Zileuton—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000115	0.00394	CcSEcCtD
Zileuton—Vomiting—Dexamethasone—ankylosing spondylitis	0.000114	0.00391	CcSEcCtD
Zileuton—Vomiting—Betamethasone—ankylosing spondylitis	0.000114	0.00391	CcSEcCtD
Zileuton—Rash—Betamethasone—ankylosing spondylitis	0.000113	0.00388	CcSEcCtD
Zileuton—Rash—Dexamethasone—ankylosing spondylitis	0.000113	0.00388	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—ankylosing spondylitis	0.000113	0.00387	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000113	0.00387	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000113	0.00386	CcSEcCtD
Zileuton—Headache—Dexamethasone—ankylosing spondylitis	0.000113	0.00385	CcSEcCtD
Zileuton—Headache—Betamethasone—ankylosing spondylitis	0.000113	0.00385	CcSEcCtD
Zileuton—Pain—Methotrexate—ankylosing spondylitis	0.000112	0.00383	CcSEcCtD
Zileuton—Pruritus—Prednisone—ankylosing spondylitis	0.000111	0.00379	CcSEcCtD
Zileuton—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000108	0.00369	CcSEcCtD
Zileuton—Diarrhoea—Prednisone—ankylosing spondylitis	0.000107	0.00366	CcSEcCtD
Zileuton—Nausea—Dexamethasone—ankylosing spondylitis	0.000107	0.00365	CcSEcCtD
Zileuton—Nausea—Betamethasone—ankylosing spondylitis	0.000107	0.00365	CcSEcCtD
Zileuton—Urticaria—Methotrexate—ankylosing spondylitis	0.000104	0.00356	CcSEcCtD
Zileuton—Dizziness—Prednisone—ankylosing spondylitis	0.000104	0.00354	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000104	0.00354	CcSEcCtD
Zileuton—Vomiting—Prednisone—ankylosing spondylitis	9.96e-05	0.0034	CcSEcCtD
Zileuton—Rash—Prednisone—ankylosing spondylitis	9.88e-05	0.00338	CcSEcCtD
Zileuton—Dermatitis—Prednisone—ankylosing spondylitis	9.87e-05	0.00337	CcSEcCtD
Zileuton—Headache—Prednisone—ankylosing spondylitis	9.82e-05	0.00335	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.65e-05	0.0033	CcSEcCtD
Zileuton—Nausea—Prednisone—ankylosing spondylitis	9.31e-05	0.00318	CcSEcCtD
Zileuton—Pruritus—Methotrexate—ankylosing spondylitis	9.27e-05	0.00317	CcSEcCtD
Zileuton—Diarrhoea—Methotrexate—ankylosing spondylitis	8.96e-05	0.00306	CcSEcCtD
Zileuton—Dizziness—Methotrexate—ankylosing spondylitis	8.66e-05	0.00296	CcSEcCtD
Zileuton—Vomiting—Methotrexate—ankylosing spondylitis	8.33e-05	0.00285	CcSEcCtD
Zileuton—Rash—Methotrexate—ankylosing spondylitis	8.26e-05	0.00282	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—ankylosing spondylitis	8.25e-05	0.00282	CcSEcCtD
Zileuton—Headache—Methotrexate—ankylosing spondylitis	8.2e-05	0.0028	CcSEcCtD
Zileuton—Nausea—Methotrexate—ankylosing spondylitis	7.78e-05	0.00266	CcSEcCtD
